Ginos - instructions for use, doses, side effects, contraindications

Ginkgo biloba leaf extract is dry, standardized by the content of ginkgo-flavonoglycosides - not less than 24% and terpenalgons: Ginkgolides A, B and C - not less than 2.8% bilobalides - not less than 2.6% 40 mg

Excipients:

Lactose monohydrate (milk sugar) 122.5 mg

Corn starch 65 mg

Povidone (polyvipylpyrrolidone) 10 mg

Sodium carbocaine-methyl starch (primogel) 7.5 mg

Magnesium stearate 2.5 mg

Aerosil (silicon dioxide colloidal) 2.5 mg

Shell

Opadrai II [Hypromellose 10 mg

(hydroxypropylmethylcellulose).

Lactose monohydrate.

Macrogol (polyethylene glycol 4000),

Titanium dioxide (G 171).

The iron oxide is black (E 172),

The iron oxide is red (E 172)

Description:

Tablets are round, biconvex, covered with a film membrane of a brick-red color. Two layers are visible on the cross-section. The inner layer is light brown with white patches.

Pharmacotherapeutic group:Angioprotective agent of plant origin

ATX: & nbsp

N.06.D.X.02 Ginkgo Biloba Leaf Extract

Pharmacodynamics:

The drug helps to strengthen and enhancing the elasticity of the vascular wall, improves the rheological properties of the blood, and as a result microcirculation improves, brain and peripheral tissues are supplied with oxygen and glucose. Ginos has angioprotective properties. Reduces the permeability of the vascular wall (anti-edematous effect - both at the level of the brain and at the periphery).The drug normalizes the metabolism in cells, prevents the aggregation of erythrocytes, inhibits the factor of platelet activation. Prevents the increase in fibrinolytic activity of the blood. Prevents formation of free radicals and peroxide oxidation of cell membrane lipids. Has a dose-dependent regulatory effect on the vascular system, dilates the small arteries, increases the tone of the veins. regulates blood vessels. The drug increases the body's resistance to hypoxia, especially brain tissue, inhibits the development of traumatic or toxic edema of the brain.

Indications:

Dyscirculatory encephalopathy (stroke, craniocerebral injury, advanced age), manifested by the following symptoms: decreased attention, memory loss, decreased intellectual ability, anxiety, dizziness, tinnitus, sleep disturbance.

Violations of peripheral circulation and microcirculation (including arteriopathy of the lower limbs), Raynaud's syndrome;

Neurosensory disorders, manifested by dizziness, ringing in the ears, deafness, unsteady gait;

Visual disturbances of vascular genesis, decreased visual acuity.

Contraindications:

Hypersensitivity to the components of the drug, decreased blood clotting, peptic ulcer of the stomach and duodenal ulcer during an exacerbation, erosive gastritis, acute disorders of cerebral circulation, acute myocardial infarction, pregnancy, the period of breastfeeding, children age (under 18), lactase deficiency, intolerance lactose, glucose-galactose malabsorption, arterial hypotension.

Carefully:

Patients with epilepsy.

Dosing and Administration:

If the other dosing regimen has not been recommended, adhere to the following recommendations for taking the drug.

For symptomatic treatment of disorders of cerebral circulation at dyscirculatory encephalopathy

1-2 tablets 3 times a day. The duration of treatment is not less than 8 weeks.

In cases of peripheral circulation disorders

1 tablet 3 times a day. The duration of the course of treatment is 6-8 weeks.

With neurosensory disorders

1 tablet 3 times a day. Duration of treatment 6-8 weeks.

Conducting repeated courses of treatment is possible after consulting a doctor.

The tablets covered with a film cover, to accept inside, not liquid, squeezed a small amount of water. The drug should be taken in the morning, afternoon and evening, while eating. If the drug was missed or if an insufficient amount was taken, follow-up should be done as described in this manual without any changes.

Side effects:

Possible allergic reactions (reddening of the skin, skin rash, swelling, itching urticaria), dyspeptic phenomena (nausea, vomiting, diarrhea), headache, dizziness, insomnia, hearing impairment, decreased blood clotting. In case of occurrence of the above-stated adverse reactions, including, not specified in the instruction, reception of a preparation should be stopped and consult with the doctor.

Overdose:

To date, cases of overdose have not been documented.

Interaction:

He recommended the use of the drug Ginos patients who are constantly taking acetylsalicylic acid and anticoagulants (direct and indirect action), thiazide diuretics, tricyclic antidepressants, anticonvulsants, gentamicin. It is not recommended simultaneous use of ginkgo biloba preparations with efavirenz, since it is possible to reduce its concentration in the blood plasma due to the induction of cytochrome CYP3A4 fashion influenced by ginkgo biloba.

Special instructions:

Do not exceed the recommended dose of the drug.

Improvement of the condition usually manifests itself 1 month after the start of treatment.

If you suddenly experience a loss of hearing or hearing loss, you should immediately seek medical help. Consultation with a doctor is also necessary for frequent dizziness and tinnitus. It is not recommended to take Ginos along with alcoholic beverages.

Effect on the ability to drive transp. cf. and fur:

During the period of taking the drug, care should be taken when carrying out potentially dangerous activities requiring increased concentration of attention and speed of psychomotor reactions (including driving, working with moving mechanisms).

Form release / dosage:

Tablets, film-coated, 40 mg.

Packaging:10 tablets per contour cell pack. For 30 tablets in a jar of polymer materials. Each jar or 3.or 9 contour mesh packages together with instructions for use in a pack of cardboard.

Storage conditions:

At a temperature of no higher than 30 ° C. Keep out of the reach of children!

Shelf life:5 years. Do not use the product after the expiration date printed on the package.

Terms of leave from pharmacies:Without recipe

Registration number:LS-000193

Date of registration:09.04.2010 / 02.10.2015

Expiration Date:Unlimited

The owner of the registration certificate:VEROPHARM SA VEROPHARM SA Russia

Manufacturer: & nbsp

VEROPHARM SA Russia

Information update date: & nbsp17.04.2017

Illustrated instructions

Instructions

Ginos® (Ginos)